Role of Public Standards in the Safety and Efficacy of Biologic Medicines
Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 3
Abstract
In this report, we emphasize the importance of public monographs with reference materials, coupled with careful process and change control and attention to GMPs, as a means of advancing access to good quality, safe, and effective medicines, with emphasis on available and incoming biologic medicines. With adequate control of articles covered by a monograph, these public standards can form the basis for a global public quality platform that covers reference products, non-interchangeable reference products, biosimilars, and interchangeable biosimilars. Working collaboratively with all stakeholders, new approaches allow these public standards to emerge nationally and globally in a timely way. Yet, there are increasing limitations in the availability of public standards for biologic medicines, which may reverse many decades of progress. Solutions are considered in this report.
Authors and Affiliations
Roger L. Williams, Adrian F. Bristow, Walter W. Hauck, V. Srini Srinivasan, Tina Morris, Fouad Atouf, Michael Ambrose, Koduru V. Surendranath, Ranjan Chakrabarty, Krishna Menon
Keywords
Related Articles
- EP ID EP681691
- DOI 10.1208/s12248-014-9586-7
- Views 71
- Downloads 0
The MDR1 C3435T polymorphism: Effects on P-glycoprotein expression/function and clinical significance
Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics
published July 14, 2000
In Vitro Characterization of a Novel Polymeric System for Preparation of Amorphous Solid Drug Dispersions
The online version of this article (doi:10.1208/s12248-014-9590-y) contains supplementary material, which is available to authorized users.
Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
The leveraged use of biomarkers presents an opportunity in understanding target engagement and disease impact while accelerating drug development. For effective integration in drug development, it is essential for biomar...
Immunotoxins for targeted cancer therapy
Immunotoxins are proteins that contain a toxin along with an antibody or growth factor that binds specifically to target cells. Nearly all protein toxins work by enzymatically inhibiting protein synthesis. For the immuno...